RT Journal Article
T1 Azathioprine-induced alopecia: a rare adverse event, early marker of myelotoxicity.
A1 Vázquez Rodríguez, Juan Antonio
A1 Merino Gallego, Esther
A1 Baños Arévalo, Antonio José
A1 Gallardo Sánchez, Francisco
A1 Miras Lucas, Leticia
A1 Pérez González, Álvaro
AB Though not exempt from adverse events, azathioprine (AZA) is an inexpensive and effective drug in the induction and maintenance treatment of patients with inflammatory bowel disease. We present the case of a 20-year-old female patient with left-side ulcerative colitis in whom AZA was started at a dose of 1.5 mg/kg/day due to dependence on corticoids (thiopurine methyltransferase activity: 14.9 U/mL). Two weeks after starting treatment she began to report excessive hair loss, resulting in an almost complete loss of scalp hair.
SN 1130-0108
YR 2022
FD 2022
LK http://hdl.handle.net/10668/21713
UL http://hdl.handle.net/10668/21713
LA en
DS RISalud
RD Apr 6, 2025